Quick Read Bristol Myers Squibb (BMY) reported Q4 2025 non-GAAP EPS of $1.26, missing consensus by 22.7% due to a $1.39B ...

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, MU has had strong sales and earnings growth: Also, EPS is estimated to ramp higher this ...

Institutional money is moving into U.S. refiners with conviction, and the earnings data backs it up. Marathon Petroleum (NYSE ...

Jones Lang LaSalle (JLL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with ...

Let's take a look at the fundamentals that came out yesterday to get a better understanding of what's going on under the hood and what the odds are for the current "recovery attempt" to continue.

CEO Prahlad Singh stated that "we closed the year on a high note, with our fourth quarter revenue, organic growth and adjusted EPS, all surpassing our expectations. This strong fourth quarter ...